Advising at the intersection of policy and market access, delivering patient-first solutions

Aery
Policy & Access
Partners

Aery Policy & Access Partners is a trusted advisor to the biopharmaceutical industry on navigating today’s most pressing drug pricing and reimbursement challenges. Leading with a 360 degree view of healthcare stakeholders, our work is bespoke, combining salient insights on present-day policy, multi-stakeholder perspectives and business acumen, we help our clients have a clear path forward for navigating a complex landscape so that their research and development may lead to breakthrough innovations for patients.

Specialties

  • MFN, IRA and MFP Strategy

  • 340B Policy and Manufacturer Strategy

  • Understanding U.S. Government Payers at the Federal and State Levels

  • Policy Strategy Related to Drug Pricing or Market Access Concerns

  • Business Mitigation Solutions

  • Intersection of Global Drug Pricing and U.S. Evolving Policies

  • Client Team Training

  • Federal Agency and Hill Education

Upcoming Speaking Highlights